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Prion disorders are infectious, neurodegenerative diseases that aﬀect humans and animals. Susceptibility to some prion diseases
such as kuru or the new variant of Creutzfeldt-Jakob disease in humans and scrapie in sheep and goats is inﬂuenced by
polymorphisms of the coding region of the prion protein gene, while other prion disorders such as fatal familial insomnia,
familial Creutzfeldt-Jakob disease, or Gerstmann-Straussler-Scheinker disease in humans have an underlying inherited genetic
basis. Several prion strains have been demonstrated experimentally in rodents and sheep. The progression and pathogenesis of
disease is inﬂuenced by both genetic diﬀerences in the prion protein and prion strain. Some prion diseases only aﬀect the central
nervous system whereas others involve the peripheral organs prior to neuroinvasion. Many experiments undertaken in diﬀerent
species and using diﬀerent prion strains have postulated common pathways of neuroinvasion. It is suggested that prions access the
autonomic nerves innervating peripheral organs and tissues to ﬁnally reach the central nervous system. We review here published
data supporting this view and additional data suggesting that neuroinvasion may concurrently or independently involve the blood
vascular system.
1.Background
Other than by direct invasion following traumatic and
iatrogenic incidents, infectious agents can gain access to
the brain by two mechanisms: using peripheral nerves as
physical conduits (neural neuroinvasion) or via the blood
(haematogenous neuroinvasion). Documented examples of
theﬁrstincludeviruses,suchaslyssavirusesorherpesviruses,
and some bacterial infections such as listeriosis. Examples of
the second include lentiviruses or ﬂaviviruses and meningi-
tides and thromboembolic encephalitides of bacterial aetiol-
ogy.
Theprecisenatureoftheinfectiousagentofthetransmis-
sible spongiform encephalopathies (TSEs) or prion diseases
is still to be determined, although the most widely accepted
theory(the“protein-only”hypothesis)isthattheyarecaused
by an infectious proteinaceous agent. This agent, usually
termed “prion” and often designated as PrPsc, hypothetically
originates as a result of an aberrant misfolding process
of the cellular, normal host prion protein (PrPc). TSEs
are a group of neurodegenerative disorders that can aﬀect
animals and humans and include, amongst others, scrapie in
sheep and goats, bovine spongiform encephalopathy (BSE),
chronic wasting disease (CWD) in cervids, transmissible
mink encephalopathy (TME), and Creutzfeldt-Jakob disease
(CJD) and its variant form (vCJD) in humans. Common
to other protein misfolding neurological disorders, like
Alzheimer’s disease, TSE-aﬀected individuals progressively
accumulate disease-associated abnormal forms of PrPc,
generically designated PrPd, in the brain and, in many
instances, in other tissues. Regardless of the precise nature of
the infectious agent, and although TSEs can be experimen-
tally or iatrogenically reproduced by a variety of routes, it
is believed that most natural infections are acquired by the
alimentary route, so that the ﬁrst barrier that the infectious
agentencountersisthegastrointestinalepithelium.Oncethis
barrierhasbeencrossed,TSEagentscouldtheoreticallyreach
the brain by the same two pathways as any other infectious
agent.
In this review we will present the ﬁndings that have led to
the prevailing hypothesis of neuroinvasion in animal TSEs,
that is, the neural route. We will also discuss whether such
ﬁndingsandrecentdataarecompatiblewithanalternativeor
complementary pathway, that is, the haematogenous route.2 Interdisciplinary Perspectives on Infectious Diseases
Emphasis will be laid on data from experimental TSE models
in rodent species and sheep, although ﬁndings arising from
natural infections in several species will also be considered.
One precaution to be taken when interpreting studies
on pathogenesis is to consider carefully the techniques
employed. In the case of TSEs, some of those studies, par-
ticularly early ones, were carried out by bioassay of selected
tissues in laboratory animal species. While this approach is
theonlyonethatcandemonstrateactualinfectivity,itcannot
determine which tissue structure or cell-type is infected
because of the diﬃculties in ﬁne dissection procedures and
the risk of cross-contamination between tissues at necropsy.
More recent and often comprehensive studies use PrPd as a
surrogate marker of infection, albeit the correlation between
the two is not always precise. The disease-speciﬁc form of
the prion protein can be detected in the brain and viscera
of TSE aﬀected animals by a number of techniques, some
of which, like ELISA or Western blot, employ extraction in
detergents and incomplete enzymatic degradation to reveal
protease-resistant PrP (PrPres). However, these techniques
still lack deﬁnition of the precise structures harbouring the
surrogate marker because sample dissection is done on fresh
or frozen tissue. PrPd detected by immunohistochemistry
(IHC) circumvents issues of potential contamination and
can be precisely ascribed to speciﬁc tissues, structures, and
cells, and even to the intra- or extracellular compartments.
Moreover, IHC is able to detect diverse morphological
types of PrPd which, depending on the protocol used, can
include both protease-resistant and protease-sensitive forms.
ByusingapanelofPrPantibodies,theintegrityoftheprotein
(full length or truncated, and their location) can also be
determined.
2.Neural Neuroinvasion:The PrevailingView
2.1. Spread of Infectivity along Nerves. A number of studies
have provided evidence in support of anterograde and
retrograde transport of prion infectivity along peripheral
nerves, and of transynaptic spread of infectivity within the
central nervous system (CNS). The most easily interpretable
paradigms arose from experiments based on cranial and
peripheral nerve challenges. Thus, intraocular injection
results in spread of infectivity along retinal ganglion axons
andoncewithinthebrainfollowstransynapticdissemination
through the visual pathways [1, 2]. Similarly, following
intralingual inoculation, infectivity ascends rapidly and
retrogradely via the XII cranial nerve reaching the hypoglos-
sal nucleus within two weeks [3]. Curiously, evidence of
transport along the olfactory nerves following intranasal
exposure is still lacking [4, 5], and only the most recent
experiments done by Bessen et al. [6] showed that only
one hamster clinically aﬀected out of ﬁve had traces of
PrPd concomitantly within the olfactory sensory epithelium
and in the glomerular layer of the olfactory bulbs. This
result suggests that some transport of infectivity by olfactory
nerves is possible although it is unclear if it would occur
anterogradely from the CNS or retrogradely from the
olfactory epithelium.
Estimates of the speed of axonal transport of prions vary
from 0.5–3 mm/day along peripheral or cranial nerves, or
within the central nervous system [7, 8]. Although these
estimates face the signiﬁcant confounding factor of the rate
at which infectivity or PrPd is ampliﬁed or accumulated
in the reporter cell or tissue, the data suggest that rates of
spread of infectivity do not precisely correspond with either
slow or fast axonal transport mechanisms. Nevertheless,
neurotropic viruses also show a similar broad range of
transport velocities; herpesviruses, for example, travel at
ratesoffastaxonaltransport[9],whilethecalculatedvelocity
o fra b i e svi ru sm a yb ea sl o wa s1 2m m / d a y[ 10]. It is diﬃcult
thereforetoconclude how prion infectivity mayspread along
neuronal processes simply from crude estimates of transport
velocity.
The numerous intranerve transmission studies provide
conclusive evidence that infectivity can be transported into
the CNS along or within axons. There is also evidence that
infection may also be transported out of the CNS along
axons. Experimental rodent infections with the agents of
scrapie and TME have shown that infection can spread from
the thoracic segments of the spinal cord to their corre-
sponding spinal [7] and to the sciatic [8] nerves. Similarly,
intracerebral challenge of deer with cattle BSE results in
PrPd in the enteric nervous system (ENS) in the absence
of lymphoid tissue involvement and only after widespread
PrPd accumulation in the brain [11]; such ﬁndings are most
probably due to anterograde transport of infectivity from the
CNS along nerve ﬁbres.
2.2. Involvement of Lymphoid Tissues and Peripheral Nerves in
TSEs. As early as 1967, studies of mouse scrapie after sub-
cutaneous injection suggested that lymphoreticular system
(LRS) tissues of hamsters such as the spleen and lymph
nodesacquiredinfectivitypriortothebrain[12].Incontrast,
Kimberlin and Walker [13] did not ﬁnd a similar role
for the spleen when a diﬀerent route was used. In those
studies,intragastricadministrationofthescrapiestrain139A
into mice concluded that agent replication in the Peyer’s
patches (PPs) occurred as fast as in the cervical lymph
nodes, and earlier than in the spleen and CNS. Furthermore,
splenectomy in those animals had no eﬀect on incubation
periods, in contrast to previous observations obtained after
intraperitoneal inoculation with the same scrapie strain [14,
15]. These results, obtained in murine models, formed the
pillars of the current neuroinvasion dogma, which suggests
that after intraperitoneal infection neuroinvasion is initiated
fromthe spleen and involves the sympathetic nervous system
[14, 15], whereas neuroinvasion after intragastric infection
is initiated directly from the intestines (via the PPs) and
involves the enteric nervous system (ENS; [13]).
Several time course studies were initiated to investigate
the spread of infectivity from the LRS to the CNS, [14,
16, 17]. Such studies reported a common neuroinvasion
pathway for the intraperitoneal, intravenous (tail vein), and
subcutaneous routes (scruﬀ of the neck and foot pad),
suggesting that neuroinvasion occurred through the spleen
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nerves such as the splanchnic nerves to the mid-thoracic
spinal cord, from where it would disseminated gradually to
therestoftheCNS(brainandlumbarspinalcord).Although
direct evidence for the initial spleen-thoracic spinal cord
pathway was lacking because of diﬃculties in sampling small
autonomic nerves and ganglia in mice, indirect evidence
based on detection of infectivity in the stromal fraction
of the spleen, in which nerve endings are abundant, was
provided [18]. At the same time, centrifugal spread from the
spinal cord and brain to peripheral nerves was demonstrated
[7, 19].
Working with orally or intraperitoneally inoculated
hamsters, Baldauf et al. [20] provided strong evidence
for an alternative route of access of the 263K strain to
the brain that bypassed the spinal cord. It was proposed
that the ﬁbres of the vagus nerve would be the most
likely direct pathway, although other cranial nerves and a
blood- or even a cerebrospinal ﬂuid- (CSF-) borne access
were not ruled out. Similar to previous data obtained by
Western blot analysis [21], spleens of infected hamsters did
not consistently show PrPres thus questioning mandatory
lymphoid tissue replication prior to neuroinvasion. Further
evidence from experimental scrapie rodent models [22–
26] conﬁrmed the early involvement of the enteric and
abdominal ganglia not only by doing infectivity assays but
also by detecting the PrPd by IHC or paraﬃn-embedded
tissue blot. Spatio-temporal studies on PrPd deposition
revealed that the dorsal motor nucleus of the vagus nerve
(DMNV) and the intermediolateral columns (IMLC) of
the thoracic spinal cord were the ﬁrst two CNS target
sites to accumulate PrPd. These authors suggested that
the infectious agent reached the CNS retrogradely from
the ENS by two diﬀerent circuits: the splanchnic nerves
circuit and the vagus nerve circuit as illustrated in Figure 1.
The splanchnic circuit involved the cranial mesenteric
and celiac ganglia and the IMLC followed by the dorsal
root ganglia. The vagus nerve circuit involved the DMNV
by passing the nodose ganglion. Subsequent experiments
demonstrated the presence of infectivity in the vagus nerve
and the cranial mesenteric ganglia by hamster bioassays
[22].
Using 263K infection of hamsters, Diringer [27]
described a low level of “viraemia” lasting for at least 40
days, with detectable amounts of infectivity in the CNS,
purportedly in capillary endothelial cells, but no sustained
replication elsewhere. Experiments using the same hamster
scrapie model discouraged consideration of haematogenous
dissemination of infectivity by describing replication in the
spleen and thoracic spinal cord earlier than in the brain
[14, 28]. Evidence for a high and persistent “viraemia” was
only available for some speciﬁc TSE models, such as the K.Fu
strain of CJD in mice [29]. Similar to experiments in mice,
thetopographical PrPd distribution using the hamstermodel
of 263K did not reveal any evidence for haematogenous
spread of infection to the brain [22]. Consequently, neuroin-
vasion in most studied rodent TSE models was thought to
becruciallydependentonanon-blood-relatedcompartment
connecting the lymphoid tissue and the CNS, that is, the
peripheral nervous system (PNS).
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Figure 1: Schematic representation of the most generally accepted
hypothesis of the routes of neuroinvasion in TSEs. Permission was
obtained for reproducing this ﬁgure originally published in [22].
DRG, dorsal root ganglia; NG, nodose ganglion; CMGC, celiac and
mesenteric ganglion complex; GI tract, gastrointestinal tract.
2.3. Support to Neural Neuroinvasion Gained from Transgenic
and Mutant Rodent Models. An important contribution
towards determining neuroinvasion pathways has been the
use of transgenic, knockout, or mutant mice. From the early
1990s, such approaches have emphasised the role of key
immune cell components in the up-take and replication
of infectivity in the periphery and their contribution in
transporting infectivity to the CNS [26]. In this respect,
Klein et al. [30, 31] found no eﬀect on susceptibility to
disease or on spleen infectivity when mice deﬁcient in
T-lymphocytes were challenged with scrapie. In contrast,
neuroinvasion was impaired in mice that were immunode-
ﬁcient only in B-lymphocytes. Further investigations using
scrapie-infected TNFα−/− mice lacking mature follicular
dendritic cells (FDCs) but not B lymphocytes [32, 33]
concluded that accumulation of infectivity and PrPres/PrPd
in spleen and subsequent neuroinvasion were dependent
upon mature FDCs. Parallel research towards investigating
the role of macrophages in TSE pathogenesis concluded that
macrophages were involved in the clearance of infectivity
[34]. Complementary studies using transgenic mice overex-
pressingPrPc highlightedtheimportanceofdeterminingPrP
interactingmoleculesorreceptorswhichmightbecrucialfor
the normal function of FDCs and the interaction with B cells
[26]. Although extensive research has focused on FDCs as
cellsforprionreplication,currentresearchhighlightstherole
of dendritic cells, B-cells and macrophages in the transfer of
infectivity from the gut to lymphoid organs [35, 36].
It is the interpolations between data obtained from all
diﬀerent animal models that have led to the most accepted
view on absorption and transport of the infectious agent
to the autonomic nervous system after oral exposure to4 Interdisciplinary Perspectives on Infectious Diseases
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Figure 2: Diagrammatic representation of the possible pathways of absorption of TSE agents from the gut lumen and their transport to the
ENS. Permission was obtained for reproducing this ﬁgure originally published in [26].
prions. Figure 2 provides a diagrammatic representation of
the possible ways by which the ENS can become infected
after oral/intragastric exposure. Many studies have focused
on the role of M cells [25], dendritic cells [37], and possibly
enteroendocrine cells as important candidates for the up-
take or absorption of infectivity from the gastrointestinal
tract. The infectious agent would then be transported to the
lymphoid follicles of the PPs, where it would replicate in a
B-cellandFDC-dependentmanner.Subsequently,infectivity
would reach nerve endings in and around the follicles and
retrograde transport of the infectious agent would occur
from the nerve endings towards the neuronal somata of
the submucosal and myenteric plexuses. Alternatively, the
agent could be transported from the gut lumen through
the absorptive epithelium of the villi and could infect nerve
endingsofthelaminapropriabeforebeingtransportedtothe
enteric plexuses [39].
Further support for the role of enteric neurons in the
disease is their high PrPc mRNA levels [40]. In parallel,
severalrodentmodelsha vebeenproducedinordertofurther
support the idea that sympathetic nerves are responsible for
transporting infectivity from the spleen to the spinal cord.
Apparently this transfer of infectivity, which is facilitated in
highly innervated spleens (as reviewed by [41]), occurs in a
PrPc-dependent fashion [42] and its rate is limited by the
splenicsympatheticinnervation[43].Thefactthatmicewith
hyperinnervated spleens showed shorter incubation periods
and higher infectivity titres and PrPd accumulation [43, 44]
supports this statement, whereas the fact that denervated
mice still develop scrapie [41] and, similarly, the failure
of splenectomy to prevent disease implies that alternative
routes participate in the neuroinvasion process and that
spleen innervation might not be a prerequisite. In this
respect, a major role of parasympathetic nerve ﬁbers like
the vagus nerve has been suspected for decades. However,
similar evidence supporting the role of the vagus nerve in
the pathogenesis of prion diseases is lacking as data from
vagotomised rodent models is not available.
2.4. Neuroinvasion in Experimental Sheep Models. The ﬁrst
studies on sheep scrapie pathogenesis date back to the
late 70s, at which period bioassay in rodents was the only
tool available to test for the presence of infectivity in
non-CNS tissues. Using such tools Hadlow et al. [45, 46]
demonstrated that scrapie infectivity replicates in the PPs
and other secondary lymphoid tissues before reaching the
CNS. Interestingly, blood was postulated as the vehicle of
infection for those peripheral LRS tissues, even though no
infectivity was detected in blood from naturally scrapie-
infected sheep at the time. Later, sheep experiments traced
infectivity by PrPd or PrPres detection, [47–51] implicating,
in addition to the PPs and other LRS tissues, the PNS, and
the ENS in the spread of infectivity to the CNS.
Cell types supporting infectivity and PrPd accumulation
are generally found throughout all lymphoid tissues, with
the exception of the thymus, and usually also in neurons
of the ENS [49, 53–55]. PrPd accumulation in LRS tissues
is found in association with mature FDCs of the light zone
and tingible body macrophages (TBMs) of the light and
dark zones of secondary follicles (Figure 3). Ultrastructural
studies conﬁrmed that PrPd within the germinal centre
of follicles locates mainly in association with the plasma
membrane of FDCs and lysosomes of TBMs [56]. At early
stages of infection, PrPd has been associated with dendritic
cells or macrophages in the dome of the PPs in addition
to cells of lymphoid tissues [53] or in the lacteals [38, 39].
The demonstration of initial PrPd accumulation in the gut-
associated lymphoid tissue (GALT) and tonsil [49, 53]o f
sheep with preclinical natural scrapie strongly supported the
hypothesis of infectivity crossing the mucosal barrier of the
gastrointestinal tract by M-cell transcytosis followed by den-
dritic cell/macrophage transport, as illustrated in Figure 2.Interdisciplinary Perspectives on Infectious Diseases 5
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Figure 3: Scrapie infection in lymphoreticular tissues in ARQ/ARQ Suﬀolk sheep. (a) PrPd accumulation is associated with both FDC and
macrophages in clinically aﬀected sheep as shown by single IHC for PrP antibody R145. Peyer’s patches of the distal ileum. (b) PrPd within
TBMsisNterminallytruncatedwhereasPrPd associatedwithFDCisnot[52].TBMandFDCcanbedistinguishedintissuesectionsbyusing
N or C terminal PrP antibodies. FDCs (brown), labelled by the N terminal antibody FH11, are in light zone whereas TBMs (purple), labelled
by the C terminal antibody R145, are both in dark and light zones of secondary lymphoid follicles: double IHC for FH11 (brown, DAB
substrate) and R145 (purple, VIP substrate). In spleen, nerve endings located in the marginal zone ((c), IHC for PgP9.5) do not colocalised
with PrPd deposition ((d), IHC for R145). (a)–(d) x20.
In a series of experiments, van Keulen and colleagues
described the temporal spread of PrPd accumulation, in the
GALT, non-GALT LRS, ENS, PNS, and CNS. They postu-
lated that scrapie pathogenesis occurred in three diﬀerent
phases (Figure 4). In the ﬁrst phase, after oral exposure to
infection, the scrapie agent would be taken up by M cells
followed by trancytosis to dendritic cells or macrophages,
which would transport infection towards the secondary
lymphoid follicles of the PPs and then drained to regional
lymph nodes. A second phase of lymphatic dissemination
would take place once infectivity is circulating the lymph
(and blood) and therefore non-GALT LRS tissues would
become involved. The fact that most data available on LRS
examinations in sheep scrapie models describe infectivity
of all lymphoid tissues at more or less the same time is
highly suggestive of blood being an early contributing factor
to dissemination of infection. Finally, neuroinvasion would
arise in a third phase as a result of infection of nerve
endings in the gut, GALT, and non-GALT LRS tissues and its
retrograde spread through sympathetic and parasympathetic
pathways.
Several sheep studies, encompassing sheep of diﬀerent
PrP genotypes, agree on the ENS being the ﬁrst neural
tissue in which PrPd can be demonstrated [49, 51, 57, 58].
In the latter study, the authors identiﬁed the duodenum
and ileum as the initial ENS sites to accumulate PrPd
and suggested subsequent spread towards the upper and
lower gastrointestinal tract [51]. Infection of the diﬀerent
plexuses of the ENS could arise from various origins ([59];
reviewed by [60]):(i) ﬁne nerve ﬁbres underneath the villous
epithelium could bring infection to the submucosal plexus;
(ii) nerve endings at follicles of the PPs could also take
infection to the submucosal plexus, (iii) indirect contact by
means of lymph or active transport between the PPs and the
ENS. In other studies, Heggebø et al. [59, 61] demonstrated
PrPd accumulation in the marginal zone of the spleen, which
isahighlyinnervatedarea.Therefore,assuggestedforrodent
models, retrograde transport from sympathetic nerve ﬁbres
connecting the spleen with the spinal cord could support
neuroinvasion in sheep scrapie. Interpretation from all these
studies postulated that entry to the DMNV was either by
ar e t r o g r a d es p r e a do fP r P d from the ENS along eﬀerent
parasympathetic ﬁbres of the vagus nerve or by anterograde
spread from other nuclei such as the nucleus of the tractus
solitarii. The fact that neurons of the trigeminal and nodose
ganglia accumulate PrPd later than the brain [51]w o u l d
suggest that these ganglia become aﬀected as a result of
descending transport.
The interval between infection and ﬁrst PrPd detection
in peripheral tissues of naturally exposed sheep will depend
on age of exposure and dose but experimental data show
that strain and genotype also markedly inﬂuence rates of
PrPd accumulation. Sheep of ARQ/ARQ genotype naturally
infected with scrapie or experimentally infected with BSE
[54, 55] accumulate PrPd in LRS tissues more slowly than
do naturally or experimentally exposed VRQ/VRQ sheep
[49, 53]. It is not clear whether these eﬀects are solely strain
or genotype eﬀects or a combination of both.6 Interdisciplinary Perspectives on Infectious Diseases
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Figure 4: Pathogenesis of sheep scrapie. Permission was obtained for reproducing this ﬁgure originally published in [53]. For abbreviations
see text.
Comprehensive pathogenetic studies have been per-
formed on sheep infected with BSE, including infectivity
assays [62] and tissue distribution of PrPd deposition by
immunohistochemistry [55, 60, 62, 63]. Despite spatio-
temporal diﬀerences reported between them, these studies
complement each other as all had in common the type of
inoculum, dose, and host PRNP genotype. Bellworthy et
al. [62] demonstrated BSE infectivity in a wide range of
tissues of ARQ/ARQ sheep including the PPs as early as 4
months postinfection, the spleen at 10m after dosing, and
other LRS tissues, CNS, and liver at 16m postinoculation. In
common with rodent studies, bioassay detecting infectivity
was more sensitive than IHC in detecting presence of PrPd.
Resistance to oral BSE infection was observed in sheep of
ARQ/ARR and ARR/ARR PRNP genotypes, which can be
overcome if the intracerebral route is used [64], although the
resulting magnitude of PrPd accumulation is lower than in
ARQ/ARQ sheep inoculated by the same route [63], and LRS
dissemination is only observed in sheep of the last genotype
[65]. Importantly, no inﬂuence of the genotype or of the
routeofinoculationwasobservedonthesignatureoftheBSE
agent in terms of intracellular truncation of BSE PrPd and
proteinase-K cleavage site of BSE PrPres. These experiments
suggest that the pathogenesis of experimental sheep BSE can
diﬀer depending on the route of inoculation and the host
PRNP genotype.
Van Keulen et al. [60] showed the progressive accumu-
lation of PrPd in 11 sheep orally dosed with cattle BSE and
killed at 6 months postinfection and thereafter at 2-3-month
interval. As with natural scrapie in VRQ/VRQ sheep, BSE-
infected ARQ/ARQ Texel sheep developed clinical disease
after peripheral accumulation of PrPd within the lymphoid
tissues and autonomic nervous system. The ﬁrst LRS tissues
to accumulate PrPd were the GALT, followed by the GALT-
draining lymph nodes and the spleen, and at a later stage,
the non-GALT lymph nodes. Similar data were found in an
earlier study albeit with some subtle diﬀerences. Jeﬀrey et
al. [54] described ﬁrst involvement of the retropharyngeal
lymph nodes prior to the PPs in Romney sheep at 4 months
post infection. Furthermore, PrPd deposition in CNS with
no apparent LRS or PNS involvement up to 22 months
postinoculation was observed in 40% (2/5) of clinically sick
sheep [55]. In the Texel sheep, by 9 month postinoculation,
PrPd was present in ENS neurons followed by the coeliac-
mesenteric ganglion and the ﬁrst two target sites in the CNS:
the IMLC in the T7-L1 segments of the spinal cord and
the DMNV in the brain. By 12-13 months dissemination
to all non-GALT tissues had taken place. Colocalization of
PrPd and CD68-positive macrophages was apparent in the
marginalzoneofspleen,suggestingapossibleactivetrapping
and phagocytosis of PrPd from circulating blood with
potential for neuroinvasion as this is a compartment highly
innervated by sympathetic autonomic ﬁbres (Figure 3(c)).
From 12-13 months postinoculation onwards spread within
the ENS and IMLC aﬀected all gastrointestinal tissues
examined and all thoracic and lumbar spinal cord levels,
respectively. It was not until 19 months postinoculation that
sheep showed clinical signs of disease and PrPd deposition in
the cerebral cortex.
2.5.NeuroinvasioninOtherNaturalTSEs. Themechanismof
neuroinvasion in cattle aﬀected with BSE remains uncertain.
Although PrPd accumulation [66] and infectivity [66–70]
has been reported in the GALT and ENS of cows orally
challenged with exceedingly high doses of BSE, in natural
BSE cases there is no known involvement of any visceraInterdisciplinary Perspectives on Infectious Diseases 7
or the PNS. A recent report of two animals that were
part of a sequential kill experiment after oral exposure to
a high dose of BSE agent concluded that BSE infectivity
is retrogradely transported from the gastrointestinal tract
to the CNS by two pathways [71]: (i) via the coeliac
and mesenteric ganglion complex, through the splanchnic
nerves towards the thoracolumbar spinal cord, and (ii)
via the vagus nerve. Such conclusions arise from ﬁnding
PrPd accumulation within the DMNV, coeliac and caudal
mesenteric ganglia, and spinal cord segments but only
in one of the reported cows. In this same experiment,
authors anticipated that the presence of PrPd in the
CNS prior to the dorsal root ganglia and possibly other
peripheral nerves, that is, sciatic nerve, could be due to
a secondary retrograde spread from the periphery to the
CNS. Although the authors suggested a neural rather than
lymphoreticular neuroinvasion-based pathway, importantly,
none of the two cows had ENS involvement or showed
PrPd in the vagus nerve even though several sections were
examined.
The pathogenesis of CWD in cervids seems to vary
between elk and deer [72]. Lymphoreticular dissemination
occurs in preclinically aﬀected deer but neuroinvasion has
been reported in elk with no LRS involvement (reviewed
by [73]). It is suspected that such diﬀerences might be
partially deﬁned by the species and the PRNP genotype.
Accumulation of PrPd in the PNS has been demonstrated in
mule deer with CWD [74], suggesting a similar pathogenesis
to that reported for small ruminants with scrapie.
The mechanisms of neuroinvasion in transmissible mink
encephalopathy (TME) have been extensively investigated
in hamster models. Early studies described two biologically
distinct strains in hamsters infected with TME, the hyper
(HY) and the drowsy (DY) strains [75]. Both strains cause
neuropathology in the CNS but only the HY disseminates
within the LRS compartment. In a large number of exper-
iments and using a variety of routes, Bartz et al. [3, 8, 76]
have demonstrated that LRS involvement is not required
for prion neuroinvasion, and that it occurs via peripheral
or cranial nerves. Recent investigations [6] conclude that
neuroinvasion is dependent on LRS involvement for speciﬁc
routes of entry such as the nasal cavity but not for others
such as the tongue (oral cavity). These diﬀerent routes
of ascending infection result in diﬀerent CNS targeting
[76].
For obvious reasons, the pathogenesis of CJD in the
natural host is the least studied amongst prion diseases. The
pathogenesis of sCJD diﬀers from that of vCJD. Accumu-
lation of PrPd is widespread in neural and lymphoreticular
tissues in vCJD, whereas it is mostly restricted to the CNS
in sCJD [77]. Consequently, tonsil and spleen biopsies are
optimal tissues for preclinical vCJD diagnosis. Deposition of
PrPd intheposteriorrootsofspinalcordwithabsenceofENS
involvement in sCJD patients is thought to be due to cen-
trifugal spread of infectivity [78]. Interestingly, some sCJD
patients with prolonged clinical periods displayed detectable
PrPres inskeletal-muscleandspleenhomogenatesbyWestern
blot analysis [79]. Unfortunately, no IHC examination was
performed in those positive samples. Thus PrPres deposition
found in muscles could have been associated with peripheral
nerves, muscle spindles, or myocytes and in spleen may have
been associated with peripheral nerves or lymphoid follicles.
2.6. Caveats in the Prevailing View of Neural Neuroinvasion.
Although the onset of PrPd accumulation in the LRS
generally occurs signiﬁcantly before that in the CNS, the
consistency and time of appearance of such depositions
varies depending on age, PRNP genotype, TSE strain, or
source and route of inoculation. Thus, it is known that
lymphoid follicles of the GALT undergo involution with age,
a n dt h i si sb e l i e v e dt oh a v ea ne ﬀect on susceptibility to
infection after oral exposure. In the case of TSEs, however,
it has been shown that such physiological involution may be
modulated by the infection itself, so that it does not seem to
occur in the GALT that accumulates PrPd [66, 80, 81]. As far
as the PRNP genotype is concerned, some earlier studies [82,
83]described lackof,orminimal, involvement ofLRS tissues
in sheep of the VRQ/ARR and VRQ/ARQ PRNP genotypes
naturally infected with scrapie. Equally, a small proportion
of scrapie-infected goats (4/72) were found to accumulate
PrPd only in the brain and not in any of 10 LRS tissues
examined; all those four animals carried the methionine
allele at codon 142 [84]. Examples of the eﬀect of the TSE
agentstrainorsourceincludenaturalBSE[69],sporadicCJD
[85], experimental CH1641 infection of sheep [38, 39], and
Nor-98 [86], in all of which PrPd accumulates in the CNS
withoutpriorreplicationinLRStissues.Therefore,toexplain
the neural neuroinvasion pathway, infection of the ENS
and other nerve terminals of the autonomic nervous system
would have to occur without previous LRS ampliﬁcation.
Replication of infectivity in the GALT and non-GALT
LRS tissues may often be demonstrated early in the disease
process. However, nerve endings in such tissues may not
necessarily become infected or if infected may not result in
retrograde transport to the CNS. Peripheral nerve terminals
can be found in the PPs of the intestine and could pick
up infectivity by contact with PrPd-containing TBMs and
FDCs. However, while a rich network of nerves is present
in the T-cell areas of the PPs—in which there is no
PrPd accumulation—, nerves are very rarely found in the
secondaryfollicles[59,80,87,88],whereFDCs,theprinciple
cellswhichamplifyinfectioninviscera,arelocated.Similarly,
nerves cannot readily be detected in secondary follicles
of other LRS tissues, particularly lymph nodes, and it is
therefore diﬃcult to see how infectivity could be transferred
from the LRS to the PNS. Moreover, morphological analysis
in confocal microscopy concluded that neuroimmune con-
nections in PPs, spleens, and mesenteric lymph nodes from
preclinical scrapie infected mice are established between
dendritic cells in T-cell areas and peripheral nerves rather
than arising from FDC in B-cell areas [36]. Although ovine
noradrenergic ﬁbres are relatively close to FDCs in the
spleen [89, 90], no direct contact has been established, and
patterns of immunolabelling for PrPd resembling nerve-like
structures have not been reported. Innervation of lymphoid
t i s s u e si sa ﬀected by the age-related involution process [91],
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during early phases of life may contribute to an increased
susceptibility of young animals to oral infection [80].
Following subcutaneous challenge, scrapie infectivity
may reach the local lymph nodes via the aﬀerent drainage
and leave via eﬀerent drainage to reach the blood. Recent
studies done in sheep indicate that infectivity reaches the
contra-lateral lymph nodes and lymph nodes distant to
the site of inoculation almost as quickly as the ipsi-lateral
nodes, suggesting that all of them were exposed more or less
simultaneously (Chianini et al. unpublished observations).
Similarly, naturally and orally challenged sheep with scrapie
generally show early and widespread involvement of all LRS,
including those that drain the head or limbs and are not
anatomicallylinkedtothealimentarysystem.Thespeedwith
whichalllymphnodesbecomeinfectedisnotconsistentwith
one lymph node or a group of lymph nodes being initially
infected and subsequently amplifying infectivity for spread
to other nodes.
The transcytosis and absorption of PrPd within a scrapie
brain homogenate placed within the gut lumen was followed
across the gut mucosa of sheep using IHC. PrPd within the
homogenate was rapidly translocated (within 15 minutes)
to mucosal and submucosal lymphatics [39]. From such a
location infectivity would rapidly reach the vascular system.
In this experiment no evidence to support transport of the
homogenateacrossthedomeandthusdirectlyintoPPscould
be found; yet this model produced accelerated infection of
PPsresultinginPrPd accumulationwithin30days,compared
with more than 8 months for the corresponding natural
disease. Thus, another possibility would be that germinal
centres of LRS tissues are most exposed to infectivity via
blood.
A recent study conducted on 67 preclinically infected
sheep exposed to natural or experimental scrapie or BSE
by various routes (oral, subcutaneous, intracerebral, or
intravenous)showedthat,regardlessoftheroute,initialPrPd
accumulation consistently occurred in the DMNV followed
by the hypothalamus [92]. These ﬁndings are diﬃcult
to reconcile with a unique neuroinvasion ENS/PNS axis
pathway. An alternative explanation would be that infection,
which is present in blood, reaches the vagus nerve from its
terminals in any organ or tissue compartment. Head et al.
[93] have published the topographical brain distribution of
amyloid plaques and lesion proﬁles of a linked human blood
donor (orally infected) and blood recipient (intravenously
infected). An almost identical severity and distribution of
plaquesandvacuoleswerefoundbothindonorandrecipient
thus supporting a common CNS portal of entry regardless of
the route of exposure.
3. Haematogenous Neuroinvasion:
The AlternativeHypothesis
3.1. Evidence for Infectivity in the Blood. Despite the fact
that intravenous infection systematically resulted in shorter
incubation periods than the intraperitoneal and subcuta-
neous routes, Kimberlin and Walker [16]w e r eu n a b l et o
ﬁnd evidence of blood infectivity by bioassay. However,
after further studies with the same 139A scrapie strain,
a short “viraemic” phase immediately after injection was
observed, leading Millson et al. [94] to conclude that the
haematogenous spread of the agent was the likely means
by which infection spread to the spleen and lymph nodes.
Subsequent rodent blood bioassay experiments showed that
a “viraemic” or “prionaemic” phase was evident early in the
incubation period [27]. In the case of infection taking place
bytheoralroute,ithasbeenproposedthatprionaemiacould
take place in two phases: an early one immediately after
cell-mediated or cell-free uptake of infection from the gut
lumen into the lymphatic system, and a second phase after
ampliﬁcation in LRS tissues [92].
An important series of experiments directed towards
establishing the risk of transmission from blood products
have provided the most comprehensive data on the presence
of infectivity in blood. Infectivity demonstrated in the blood
of BSE-infected sheep [92, 95, 96, 99], of natural scrapie
cases [95, 100, 101] ,a n do fC W D - i n f e c t e dd e e r[ 102]a g r e e s
with data suggesting that vCJD can be transmitted by blood
transfusion from donors incubating the disease. Descrip-
tions of ﬁve transfusion-related vCJD cases have conﬁrmed
transmission of infection by blood-derived products [103–
107]. Moreover, sheep experiments have shown that scrapie
and BSE may be transmitted with blood collected early in
the incubation period, even before any other evidence of
infection is apparent [92, 95, 96], although the likelihood of
transmission increased together with the incubation period
in the blood donors. This would imply that infectivity in
blood is an early and permanent (maybe even progressive)
event rather than a transient one, in contradiction with the
resultsonPrPres detectioninthebloodofhamstersbyprotein
misfolding cyclic ampliﬁcation [108].
3.2. Evidence That Infectivity in Blood May Establish Tissue
Infection. Haematogenous dissemination of infection may
haverelevanceformorethanoneaspectofTSEpathogenesis.
Experiments with blood transfusions in sheep demonstrated
how the route, oral (BSE donors) versus intravenous (BSE
recipients) can aﬀect peripheral pathogenesis (Figure 5).
Although a similar scenario might be predicted for vCJD, it
remains to be established if spleens of vCJD patients infected
after receiving blood fractions contain higher PrPd mag-
nitudes than those from patients infected by consumption
of BSE-contaminated products. Accumulation of PrPd can
be demonstrated in placenta [109], mammary gland [110],
salivary glands [111], and kidney [96, 97, 112]o fT S E -
aﬀected sheep. In the latter, with both scrapie [112]a n d
BSE (S. Sis´ o, personal observations) infections, PrPd can
be detected in mesenchymal cells between collecting ducts
and loops of Henle in the renal pelvis in the absence of
inﬂammation, suggesting that mesenchymal cells become
infected from blood after ﬁltration in the glomeruli or by
extravasation from the vasa recta. Also in sheep, PrPd in the
mammarygland [110,113]andinfectivityinmilk[113,114]
also most probably derive from the blood, as it does in
scrapie-aﬀected goats, in which accumulation of PrPd in the
mammary gland only occurred in animals with widespreadInterdisciplinary Perspectives on Infectious Diseases 9
0.5
1
1.5
2
2.5
3
3.5
4
4.5
P
r
P
d
s
c
o
r
e
Tonsil MsLN Spleen
Tissue
BSE donor
BSE recipient
Scrapie donor
Scrapie recipient
Figure 5: Magnitude of PrPd accumulation in LRS tissues of
sheep as part of the blood transfusion experiment [95]. BSE donor
sheep showed the highest levels of PrPd accumulation in palatine
tonsil and mesenteric lymph node (MsLN) but the lowest in the
s p l e e n .I nc o n t r a s t ,t h es p l e e ni nB S E - t r a n s f u s e ds h e e ps h o w e d
signiﬁcant higher magnitudes of PrPd. Graphic representation
including scrapie data has been modiﬁed from [96, 97].
LRS involvement regardless of the involvement or otherwise
ofneuraltissues[115].Inthegutloopexperimentsdescribed
previously [39], in which PrPd was detected rapidly in
lymphatics, PPs of the intestine became infected at an early
disease stage: as no evidence was obtained for the inoculum
being transported across the dome to the PPs, the most likely
source of scrapie infection of FDCs is thought to be from
blood.
3.3. Evidence That Infectivity in Blood May Establish Brain
Infection. In the brains of BSE-infected sheep, the distri-
bution of PrPd was found to be similar irrespective of the
route of inoculation being intravascular, intracerebral, or
alimentary [63], suggesting common patterns of neuroin-
vasion and CNS spread. The ﬁndings of vascular amyloid
PrPd deposition in the basement membrane of endothelial
cells of the hypothalamus [51] were an early indication that
infectivity could reach the brain from the blood. However,
such vascular PrPd plaques are a relatively rare ﬁnding
in TSEs [116], which would not justify haematogenous
neuroinvasionbeingafrequenteventorhavinganimportant
role.
It is generally accepted that access of infectious agents to
the brain via the blood is hampered by a defensive mech-
anism: the so-called blood-brain barrier. However, there
are speciﬁc structures in the brain, the circumventricular
organs (CVOs) which, having fenestrated capillaries, are
more permissive than other brain areas to the passage of
large molecules and provide a two-way communication
between CNS and the rest of the body. Recent studies
have shown that PrPd accumulation in the CVOs of sheep
was an early and consistent event that was not aﬀected
by the route of challenge or TSE strain, suggesting that
CNS entry of infectivity can occur through these structures
[92]. No evidence has been obtained that arrival of PrPd
in the CVOs is cell-mediated, as white blood cells were not
observed in these organs at preclinical or clinical stage of
disease; it is therefore possible that TSE agents are present
in plasma as cell-free, soluble molecules. This hypothesis
would be reinforced by the above-mentioned ﬁndings of
PrPd inkidneysofscrapie-aﬀectedsheep[96,97,112],which
suggest that PrPd arrives in the renal papillary interstitium
by ﬁltration or extravasation of soluble molecules. Similarly,
CVOs could initially up-take soluble infectivity present in
plasma (or in CSF) and act as receptors, supporters, and
transporters of infectivity. The variability in severity of
PrPd accumulation observed between examined CVOs may
suggest diﬀerent participation of these organs in terms
of acquiring and amplifying infectivity. Hypothetically, the
sensory CVOs may be more susceptible to initial infection,
and the secretory CVOs in releasing it to extracranial
structures; that is, infectivity present in the pituitary gland
may be transported into the adrenal gland.
OnceinfectionisestablishedinthesensoryCVOsfurther
spread to neighbouring neural structures through eﬀerent
connections could occur (Figure 6). Thus, for example,
PrPd in the hypothalamic paraventricular nucleus and in
the bed nucleus of the stria terminalis could result from
spread from the subfornical organ and from the organum
vasculosum of the lamina terminalis rather than from
the DMNV. The involvement of the DMNV and the area
postrema is often simultaneous [98, 115] making it diﬃcult
to determine if the mechanism of entry of infection at
this level of the brain is through the vagus nerve or from
the blood, or from both. If the access was from blood
through the area postrema, or through CVOs in general, it
is possible that neurons of these organs would be infected
andwouldstarttoaccumulatePrPd assoonasanycirculating
infectivity in blood reaches them. However, it might also be
possible that neurons of neighbouring structures, such as the
DMNV or the hypothalamus, to which CVOs are connected,
amplify infectivity or accumulate PrPd more rapidly than
CVO neurones, resulting in an earlier detection in those
structures.
Until recently, the CVOs had received no or very little
attention in any human or animal TSE. McBride et al.
[22] reported absence of PrPd immunodeposits in the area
postremaofhamstersexperimentallyinoculatedwithscrapie
by the oral route but investigations did not address the
involvement of other CVOs. Similarly, no CVOs were studied
in mule deer with chronic wasting disease, in which the
hypothalamus was reported to accumulate PrPd before the
medulla but after the DMNV [117]. We routinely examine
the CVOs in current experiments and have retrospectively
examined formalin-ﬁxed brains from earlier studies. So far,
we have found PrPd deposition in CVOs from clinically
aﬀected animals of diﬀerent species infected with several
strains (Figure 7), such as in mice intracerebrally infected
with ME7, 87V, 79A, 22A, and 301V strains, and deer
[11] and cattle orally infected with cattle BSE, (Sis´ oe ta l .
unpublished observations) and in goats with natural scrapie
[115].10 Interdisciplinary Perspectives on Infectious Diseases
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Figure 6: CVO involvement may contribute to the spread of infection into the brain parenchyma. Preclinically aﬀected TSE sheep show mild
early PrPd accumulation in the median eminence (ME) (a; x4), or severe deposition in later stages (b; x4). Higher magniﬁcation is needed
to detect mild PrPd accumulation in the ME (c; x60). In later stages, preclinical sheep do show accumulation of PrPd in those brain areas
with established connections with the CVOs. A sagittal section of the diencephalon (d; x1) has been produced from the area compressed in
the white rectangle in the macroscopic sagittal view of the brain highlighting some of the neural structures. Thus, the involvement of the
ME correlates with PrPd accumulation in the arcuate nucleus (ARQ) (a,b,e), and that of the organum vasculosum of the lamina terminalis
(OVLT) and the subfornical organ (SFO) correlates with PrPd in several nuclei: preoptic (PON) (f, x1), suprachiasmatic (SQN) (g; x4),
supraoptic (SOP) (e, x1), paraventricular (PVN) (d,e), bed nucleus of the stria terminalis (BNST) (d) and perifornical (PFN) (f). Such
correlations are diﬃcult in the vagal complex because of the widespread severe PrPd accumulation (h).
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Figure 7: PrPd accumulation within CVOs in clinically aﬀected animals with diﬀerent TSE strains. AP, area postrema; PG, pineal gland;
ME, median eminence; SCO, subcommisural organ; OVLT, organum vasculosum of lamina terminalis; SFO, subfornical organ; NH,
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Figure 8: PrPd accumulation in CVOs and in the porencephalic lesion. Sheep CVOs highlighted with an asterix in pictures (a–f) of low
magniﬁcation showed consistent PrPd deposition after intracerebral inoculation with BSE. Note that the porencephalic lesion which is
surrounded by PrPd accumulations (g; x10) has abundant proliferation of newly formed vessels as revealed by a Van-Gieson staining (h;
x20). CVOs: AP, area postrema; PG, pineal gland; ME, median eminence; SCO, subcommisural organ; OVLT, organum vasculosum of the
lamina terminalis; SFO, subfornical organ. Brain structures: DMNV, dorsal nucleus of the vagus nerve; IV, fourth ventricle; Saq, Silvios’
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A further support for a blood-borne neuroinvasion
pathway was provided by the study of the topographical
distribution of PrPd in the brain of 27 sheep that had
been intracerebrally challenged with BSE and presented
porencephalic lesions resulting from the traumatic injury
[98]. The key ﬁndings (Figure 8)w e r ea sf o l l o w s :( i )
same PrPd topography, involving bilaterally the DMNV and
the hypothalamus, as for infections by other routes; (ii)
involvement of CVOs; (iii) focal accumulation of PrPd at
the porencephalic lesions, but extending locally to neigh-
bouring ipsilateral cerebrocortical areas in some cases; and
(iv) absence of PrPd in such lesions in cases that did
not accumulate PrPd anywhere else in the brain. It was
therefore suggested that, rather than a local replication of the
infectious agent at the site of injection, the inoculum would
be completely reabsorbed into the CSF and recirculated in
the blood gaining access back to the brain through the CVOs
and through the porencephalic lesions, where fenestrated
neocapillaries were also abundant as part of the repair tissue
process.
The haematogenous route, therefore, can represent a
parallel or alternative pathway of neuroinvasion to ascending
infection via the ENS and autonomic nervous system by
accessing the CVOs and encephalic lesions of traumatic
or vascular origin. Figure 9 represents schematically the
possiblepathwaysofneuroinvasiontobeconsideredinTSEs.
4. Conclusions
The most widely accepted neuroinvasion mechanism in
prion diseases is thought to involve ampliﬁcation of infec-
tivity within lymphoid tissues and subsequent retrograde
spread of infection along autonomic nervous system nerves
until it reaches the brain. However, the peripheral patho-
genesis of prion diseases can vary depending on several
factors. In most TSE cases, infection of the lymphoid system
appears to facilitate neuroinvasion, increasing attack rates
andshorteningincubationperiods,althoughinsomescrapie
cases and in most or all of natural BSE cases and in sCJD,
the lymphoid system does not seem to be involved. In view12 Interdisciplinary Perspectives on Infectious Diseases
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of the fact that, regardless of the route of infection and
other factors that aﬀect the peripheral pathogenesis (agent,
PRNP genotype, etc.), the initial accumulation of PrPd in the
brain and its spread appears to follow the same pattern, it
is unlikely that neuroinvasion occurs solely by a mechanism
involving retrograde transport of infectivity along peripheral
nerves, at least those of the ENS/PNS axis, as the prevailing
view suggests.
Alternatively, the observation that PrPd accumulates in
peripheral organs, such as the kidney or the mammary
gland, as does in the LRS tissues themselves, clearly shows a
vascular dispersion of infectivity, which is consistent with an
haematogenous route of neuroinvasion. Additional support
for this alternative pathway derives from the early and
systematic detection of PrPd in the CVOs which, lacking
a blood-brain barrier, could act as portals of entry of
infection.
Whether the haematogenous neuroinvasion pathway is
coincidental with a neural pathway, and the relative impor-
tance of them for diﬀerent TSEs, remains to be determined.
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